Stocks FUTU Financial statements
Financial statementsFutu Holdings Ltd financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Futu Holdings Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 136 | 427 | 912 | 976 | 1,281 | 1,750 | 2,935 |
| Cost of revenue | 36.2 | 89.8 | 155 | 128 | 197 | 315 | 378 |
| Gross profit | 100 | 337 | 758 | 848 | 1,085 | 1,435 | 2,557 |
| Research and development | 33.7 | 66.2 | 103 | 157 | 184 | 192 | 245 |
| Selling and marketing | 21.1 | 49.7 | 178 | 115 | 90.9 | 181 | 254 |
| General and administrative | 21.2 | 32 | 67.8 | 119 | 168 | 209 | 249 |
| Operating expenses | 76 | 148 | 350 | 391 | 444 | 582 | 748 |
| Operating income | 641 | 852 | 1,809 | ||||
| Other non-operating income | -1.22 | -2.22 | 0.32 | -27 | 4.28 | -11.1 | -47.2 |
| Pre-tax income | 22.9 | 187 | 408 | 431 | 645 | 841 | 1,762 |
| Income tax | 1.58 | 16.1 | 48.1 | 53.1 | 95.8 | 129 | 303 |
| Net income to minority interests | -0.01 | -0.32 | -1.29 | -4.6 | |||
| Net income | 21.3 | 171 | 360 | 375 | 548 | 701 | 1,457 |
| EBITDA | 649 | 861 | 1,818 | ||||
| EPS, basic | 0.02 | 0.16 | 0.30 | 0.33 | 0.50 | 0.63 | 1.31 |
| EPS, diluted | 0.02 | 0.16 | 0.30 | 0.33 | 0.49 | 0.63 | 1.29 |
| Shares, basic (weighted) | 833 | 1,037 | 1,201 | 1,139 | 1,105 | 1,104 | 1,114 |
| Shares, diluted (weighted) | 918 | 1,050 | 1,220 | 1,151 | 1,120 | 1,120 | 1,131 |
Balance sheet
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 46.5 | 133 | 584 | 645 | 632 | 1,505 | 1,345 |
| Short-term investments | 150 | 86.5 | 399 | 310 | 859 | ||
| Other current assets | 10.5 | 13.1 | 17.3 | 20.6 | 29 | ||
| Total current assets | 12,911 | 11,929 | 12,217 | 20,068 | 28,735 | ||
| Lease right-of-use assets | 20.7 | 26.9 | 31.3 | 25.2 | 28.7 | 32.6 | 73.2 |
| Long-term investments | 3 | 30.7 | 30.5 | 73.8 | 79 | ||
| Other non-current assets | 72.9 | 124 | 157 | 261 | 445 | ||
| Total assets | 2,747 | 9,201 | 13,018 | 12,113 | 12,436 | 20,438 | 29,350 |
| Total current liabilities | 10,305 | 9,425 | 9,273 | 16,815 | 24,116 | ||
| Lease liabilities | 21 | 13 | 15.8 | 17.1 | 50.6 | ||
| Other non-current liabilities | 1.4 | 1.75 | 1.56 | 1.04 | 2.82 | ||
| Total liabilities | 2,420 | 8,129 | 10,328 | 9,439 | 9,290 | 16,833 | 24,169 |
| Paid-in capital | 326 | 898 | 2,300 | 2,327 | 2,363 | 2,421 | 2,461 |
| Retained earnings | 2.15 | 173 | 532 | 907 | 1,454 | 1,886 | 3,339 |
| Treasury stock | -151 | -554 | -666 | -669 | -668 | ||
| Other comprehensive income | -0.57 | 0.64 | 9.74 | -6.13 | -6.33 | -32.2 | 6.62 |
| Shareholders' equity | 327 | 1,071 | 2,691 | 2,674 | 3,145 | 3,606 | 5,139 |
| Minority interests | 0.03 | 0.38 | -0.87 | 41.1 | |||
| Total equity | 327 | 1,071 | 2,691 | 2,674 | 3,146 | 3,605 | 5,180 |
| Total liabilities and equity | 2,747 | 9,201 | 13,018 | 12,113 | 12,436 | 20,438 | 29,350 |
| Shares outstanding | 0 |
Cash flow statement
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 21.3 | 171 | 360 | 375 | 548 | 699 | 1,452 |
| Depreciation and amortization | 2.12 | 3.51 | 4.67 | 7.01 | 7.79 | 9 | 9.29 |
| Stock-based compensation | 2.05 | 4.2 | 12.7 | 26.2 | 37.2 | 43.1 | 44.1 |
| Deferred income tax | -10.1 | ||||||
| Cash from operations | 253 | 2,638 | 771 | 445 | -811 | 3,990 | 5,240 |
| Capital expenditures | -15.2 | -5.76 | -9.03 | -11.6 | -9.96 | -21.6 | -7.03 |
| Purchases of investments | -36.7 | -26.7 | -150 | -521 | -609 | -103 | -422 |
| Sales and maturities of investments | 32.1 | 39.5 | |||||
| Cash from investing | -20.5 | -31.5 | -124 | 12 | -313 | 13.4 | -229 |
| Stock issued | 0.12 | 302 | 1,392 | 2.09 | 1.49 | 2.6 | 1.02 |
| Share buybacks | -151 | -403 | -112 | ||||
| Dividends paid | -276 | ||||||
| Cash from financing | 148 | 1,084 | 1,353 | -898 | 295 | 9.12 | 552 |
| Exchange rate effect | -5.73 | -0.14 | 21.4 | ||||
| Net change in cash | 374 | 3,691 | 2,022 | -458 | -820 | 3,994 | 5,594 |
| Free cash flow | 238 | 2,633 | 762 | 434 | -821 | 3,969 | 5,233 |
| Interest paid | 11.5 | 23.4 | 47.1 | 38.2 | 112 | 203 | 230 |
| Income taxes paid | 1.94 | 2.1 | 13.2 | 89.1 | 89.5 | 98.1 | 212 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 87.1% | Gross profit / revenue. |
| Operating margin | 61.6% | Operating income / revenue. |
| EBITDA margin | 61.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 60.0% | Pre-tax income / revenue. |
| Net margin | 49.6% | Net income / revenue. |
| FCF margin | 178.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 178.5% | Cash from operations / revenue. |
| Effective tax rate | 17.2% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 33.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 5.9% | Net income / average total assets. |
| Return on invested capital (ROIC) | 50.8% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 8.4% | Research and development expense / revenue. |
| Stock-based pay / revenue | 1.5% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.2% | Capital expenditures / revenue. |
| D&A / revenue | 0.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 67.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 44.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 47.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 78.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 44.5% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 50.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 112.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | 111.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | 107.9% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 57.2% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 53.5% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 104.8% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 57.5% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 51.8% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 31.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 127.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 14.7% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 31.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 129.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 14.7% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 42.5% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 24.3% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 36.8% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 43.6% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 34.3% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 26.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.9% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 1.5% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.19x | Current assets / current liabilities. |
| Quick ratio | 0.09x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.09x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 82.3% | Total liabilities / total assets. |
| Working capital | $4.62B | Current assets - current liabilities. |
| Tangible book value | $5.14B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.12x | Revenue / average total assets. |
| FCF conversion | 359.3% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 0.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.29 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $1.31 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $2.60 | Revenue / diluted weighted shares. |
| FCF per share | $4.63 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $4.63 | Cash from operations / diluted weighted shares. |
| Book value per share | $4.54 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $4.54 | Tangible book value / shares outstanding. |
| Cash per share | $1.95 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 19.0% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 5.3% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $15.68B | Share price x shares outstanding. |
| Enterprise value | $13.48B | Market cap + total debt - cash - short-term investments. |
| P/E | 10.8x | Market cap / net income. Only when net income is positive. |
| P/S | 5.34x | Market cap / revenue. |
| P/B | 3.05x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.05x | Market cap / tangible book value, when positive. |
| P/FCF | 3.00x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 2.99x | Market cap / cash from operations, when positive. |
| EV/Sales | 4.59x | Enterprise value / revenue. |
| EV/EBIT | 7.45x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 7.41x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 2.58x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 33.4% | Free cash flow / market cap. |
| Earnings yield | 9.3% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.8% | Dividends paid over the period / market cap. |
| Shareholder yield | 1.8% | (Dividends paid + share buybacks) / market cap. |
| PEG | 0.19x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Futu Holdings Ltd's revenue in fiscal 2025?
Futu Holdings Ltd reported revenue of $2.94B for fiscal 2025, 67.8% higher than the year before.
Was Futu Holdings Ltd profitable in fiscal 2025?
Yes. Net income was $1.46B, a net margin of 49.6%.
How much free cash flow did Futu Holdings Ltd generate in fiscal 2025?
Cash from operations of $5.24B minus capital expenditures of $7.0M left free cash flow of $5.23B.